Metraipolis › archive › dc_d94cc32328ad

Neuroinflammation as a Novel Therapeutic Frontier for Sanfilippo Syndrome — Europe PMC PMID:41300647

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41300647
DOI
10.3390/children12111530
License (as archived)
solo-consultazione
Archived
2026-11-08T14:59:28.745Z
SHA-256 of the archived text
fc8b77d5282de7dd05179defd258f18ca9f05370ce5da2d4472bcc042def788d
Stable URL of this page
https://metraipolis.com/documento/dc_d94cc32328ad

How to cite

Neuroinflammation as a Novel Therapeutic Frontier for Sanfilippo Syndrome — Europe PMC PMID:41300647 — Europe PMC (en), https://europepmc.org/article/MED/41300647 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d94cc32328ad (Metraipolis archive dc_d94cc32328ad, sha256 fc8b77d5282de7dd05179defd258f18ca9f05370ce5da2d4472bcc042def788d)
BibTeX
@misc{dcd94cc32328ad,
  title = {Neuroinflammation as a Novel Therapeutic Frontier for Sanfilippo Syndrome — Europe PMC PMID:41300647},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41300647},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d94cc32328ad; sha256 fc8b77d5282de7dd05179defd258f18ca9f05370ce5da2d4472bcc042def788d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41300647. Agents can read the archived copy with the MCP tool read_document.